Annual Shareholders Equity
$277.69 M
-$49.62 M-15.16%
December 31, 2023
Summary
- As of February 7, 2025, DSGN annual stockholders equity is $277.69 million, with the most recent change of -$49.62 million (-15.16%) on December 31, 2023.
- During the last 3 years, DSGN annual shareholders equity has risen by +$289.00 million (+2554.15%).
- DSGN annual shareholders equity is now -27.33% below its all-time high of $382.13 million, reached on December 31, 2021.
Performance
DSGN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$252.45 M
-$8.79 M-3.36%
September 30, 2024
Summary
- As of February 7, 2025, DSGN quarterly stockholders equity is $252.45 million, with the most recent change of -$8.79 million (-3.36%) on September 30, 2024.
- Over the past year, DSGN quarterly shareholders equity has dropped by -$8.79 million (-3.36%).
- DSGN quarterly shareholders equity is now -38.13% below its all-time high of $408.01 million, reached on March 31, 2021.
Performance
DSGN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
DSGN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.2% | -3.4% |
| 3 y3 years | +2554.2% | -35.5% |
| 5 y5 years | +7724.6% | - |
DSGN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.3% | at low | -33.9% | at low |
| 5 y | 5-year | -27.3% | +2554.2% | -38.1% | +2331.1% |
| alltime | all time | -27.3% | +2554.2% | -38.1% | +2331.1% |
Design Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $252.45 M(-3.4%) |
| Jun 2024 | - | $261.24 M(-3.1%) |
| Mar 2024 | - | $269.56 M(-2.9%) |
| Dec 2023 | $277.69 M(-15.2%) | $277.69 M(-2.6%) |
| Sep 2023 | - | $284.96 M(-4.0%) |
| Jun 2023 | - | $296.80 M(-5.1%) |
| Mar 2023 | - | $312.82 M(-4.4%) |
| Dec 2022 | $327.31 M | $327.31 M(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $340.94 M(-4.5%) |
| Jun 2022 | - | $357.16 M(-3.6%) |
| Mar 2022 | - | $370.31 M(-3.1%) |
| Dec 2021 | $382.13 M(-3477.2%) | $382.13 M(-2.4%) |
| Sep 2021 | - | $391.56 M(-2.5%) |
| Jun 2021 | - | $401.60 M(-1.6%) |
| Mar 2021 | - | $408.01 M(-3705.9%) |
| Dec 2020 | -$11.31 M(+210.7%) | -$11.31 M |
| Dec 2019 | -$3.64 M | - |
FAQ
- What is Design Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Design Therapeutics?
- What is Design Therapeutics annual shareholders equity year-on-year change?
- What is Design Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Design Therapeutics?
- What is Design Therapeutics quarterly shareholders equity year-on-year change?
What is Design Therapeutics annual stockholders equity?
The current annual shareholders equity of DSGN is $277.69 M
What is the all time high annual shareholders equity for Design Therapeutics?
Design Therapeutics all-time high annual stockholders equity is $382.13 M
What is Design Therapeutics annual shareholders equity year-on-year change?
Over the past year, DSGN annual stockholders equity has changed by -$49.62 M (-15.16%)
What is Design Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of DSGN is $252.45 M
What is the all time high quarterly shareholders equity for Design Therapeutics?
Design Therapeutics all-time high quarterly stockholders equity is $408.01 M
What is Design Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, DSGN quarterly stockholders equity has changed by -$8.79 M (-3.36%)